Lantheus makes pharma veteran Jeffrey Bailey CEO
This article was originally published in Clinica
Imaging agent specialist Lantheus Medical Imaging has appointed Jeffrey Bailey as its president and CEO, succeeding Donald Kiepert, who has resigned "to pursue other opportunities" after leading the firm for five years. Mr Bailey was previously chief operating officer of Fougera Pharmaceuticals, a position he held since 2011. Before this, he was COO of King Pharmaceuticals (from August 2010 until August 2011); general manager at Novartis (2008-2010); and national sales director for Johnson & Johnson (1984-2006) and its Janssen Pharmaceutica division (2004-2006). Lantheus has also named a new chairman, Brian Markison, who has been a board member since September.